IL-17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer via the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways

Figure 3

IL-17 colocalized with FAS/FASL in laryngeal carcinoma cells in vitro. (a) LC cells were exposed to 50 ng/mL of 200-17 for 6 h and were immunostained with antibodies against FAS (red) and DAPI (blue), followed by confocal microscopy. (b) LC cells were exposed to 50 ng/mL of 200-17 for 6 h, and then they were immunostained with antibodies against FASL (red) and DAPI (blue), followed by confocal microscopy.

(a)

(b)